39 results on '"Lippmann, S"'
Search Results
2. Fibromyalgia, Sjogren's & depression: linked?
- Author
-
Loganathan M, Ladani A, and Lippmann S
- Subjects
- Depression diagnosis, Diagnosis, Differential, Fatigue complications, Fibromyalgia classification, Fibromyalgia diagnosis, Humans, Severity of Illness Index, Sjogren's Syndrome classification, Sjogren's Syndrome diagnosis, Depression complications, Fibromyalgia complications, Sjogren's Syndrome complications
- Abstract
Health care has become increasingly fragmented, partly due to advancing medical technology. Patients are often managed by various specialty teams when presenting with symptoms that could be manifestations of different diseases. Approximately one third of them are referred to specialists, at over half for outpatient appointments. Fatigue, pain, depression, dry mouth, headaches, and arthralgia are common complaints and frequently require referral to specialist physicians. Differential diagnoses include fibromyalgia (FM), Sjogren's syndrome (SS), and depression. Evaluations involve various sub-specialist especially physicians like those practicing pain management, rheumatology, and psychiatry. Thresholds for referring vary. Patients sometime feel lost in a 'medical maze'. Disagreement is frequent between specialties regarding management. Each discipline has its own diagnostic and treatment protocols and there is little consensus about shared decision-making. Communication between doctors could improve continuity. There are many differences and similarities in the pathophysiology, symptomatology, diagnosis, and treatment of fibromyalgia, Sjogren's syndrome, and depression. Understanding the associations between fibromyalgia, Sjogren's syndrome and depression should improve clinical outcome via a common holistic approach.
- Published
- 2020
- Full Text
- View/download PDF
3. Do you know about Kratom?
- Author
-
Eladely AA, Shahzad J, and Lippmann S
- Subjects
- Humans, Opioid-Related Disorders drug therapy, Mitragyna, Pain Management methods, Phytotherapy methods, Plant Preparations therapeutic use, Substance Withdrawal Syndrome drug therapy
- Published
- 2020
- Full Text
- View/download PDF
4. Gut microbiota and health.
- Author
-
Kc D, Sumner R, and Lippmann S
- Subjects
- Brain immunology, Brain metabolism, Brain physiopathology, Clostridium Infections microbiology, Clostridium Infections therapy, Dysbiosis immunology, Fecal Microbiota Transplantation, Gastrointestinal Diseases microbiology, Gastrointestinal Diseases therapy, Gastrointestinal Microbiome immunology, Humans, Mental Disorders immunology, Mental Disorders microbiology, Metabolic Syndrome metabolism, Metabolic Syndrome microbiology, Metabolic Syndrome therapy, Prediabetic State metabolism, Prediabetic State microbiology, Prediabetic State therapy, Probiotics therapeutic use, Dysbiosis metabolism, Gastrointestinal Microbiome physiology
- Published
- 2020
- Full Text
- View/download PDF
5. Procedural sedation: not to be routine.
- Author
-
Lippmann S and Sumner R
- Subjects
- Decision Making, Humans, Informed Consent, Pain, Procedural prevention & control, Patient Preference, Conscious Sedation methods, Endoscopy methods
- Published
- 2019
- Full Text
- View/download PDF
6. Measles 101.
- Author
-
Nathala P, Fatima S, Sumner R, and Lippmann S
- Subjects
- Anti-Vaccination Movement, Humans, Measles diagnosis, Measles therapy, Measles prevention & control, Measles-Mumps-Rubella Vaccine therapeutic use, Vaccination Refusal
- Published
- 2019
- Full Text
- View/download PDF
7. Anxiety in geriatrics.
- Author
-
Pary R, Sarai SK, Sumner R, and Lippmann S
- Subjects
- Anti-Anxiety Agents therapeutic use, Anxiety Disorders diagnosis, Anxiety Disorders therapy, Chronic Disease, Diagnosis, Differential, Health Behavior, Humans, Life Style, Patient Care Management, Patient Education as Topic, Anxiety Disorders epidemiology, Geriatrics
- Published
- 2019
- Full Text
- View/download PDF
8. Vaping medical marijuana.
- Author
-
Singh D and Lippmann S
- Subjects
- Administration, Inhalation, Humans, Medical Marijuana adverse effects, Medical Marijuana administration & dosage, Vaping
- Published
- 2018
- Full Text
- View/download PDF
9. Modafinil Treatment of Cocaine Dependence: A Systematic Review and Meta-Analysis.
- Author
-
Sangroula D, Motiwala F, Wagle B, Shah VC, Hagi K, and Lippmann S
- Subjects
- Benzhydryl Compounds adverse effects, Humans, Modafinil, Benzhydryl Compounds therapeutic use, Cocaine-Related Disorders drug therapy
- Abstract
Background: Currently, there is none FDA-approved medication to treat cocaine dependency. Studies conducted with various medications, including antipsychotics, antidepressants, anticonvulsants, and others, revealed inconsistent results., Objectives: To meta-analytically investigate the efficacy and safety of modafinil in the treatment of cocaine-dependent patients., Methods: Randomized controlled trials with ≥20 subjects comparing the numerical therapeutic outcomes of modafinil with placebo were identified in databases, such as PUBMED, psycINFO, EMBASE, and Clinicaltrials.gov. Relevant data on efficacy and safety were extracted. Relative risk (RR) and standardized mean difference were applied for reporting dichotomous and continuous outcomes respectively. Random effects, subgroup, and meta-regression analyses were conducted to further explore the results and evaluate for any moderators., Results: In total, 11 studies (participants = 896, duration = 6.7 ± 1.9 weeks) comparing modafinil with placebo were systematically analyzed, which indicated that modafinil was not superior to placebo in improving the treatment retention rate (studies = 11, participants = 891, RR = 1.030, 95% CI = 0.918-1.156, p = .613). Similarly, data from 7/11 studies did not evidence superiority of modafinil in achieving cocaine abstinence (participants = 696, RR = 1.259, 95% CI = 0.813-1.949, p = .302). However, subgroup analysis of six studies conducted in the United States demonstrated superiority of modafinil in cocaine abstinence rate (studies = 6, participants = 669, 95% CI = 1.027-2.020, p = 0.035). In addition, no evidence suggested modafinil-related discontinuation or specific adverse events than placebo., Conclusions: Overall, there is no evidence to conclude superiority of modafinil in increasing cocaine abstinence and treatment retention rate. However, promising result in subgroup analysis of cocaine abstinence, secondary outcomes, and good safety profile urged the need of larger studies to derive more conclusive results.
- Published
- 2017
- Full Text
- View/download PDF
10. Kocuria kristinae infection during adalimumab treatment.
- Author
-
Kolikonda MK, Jayakumar P, Sriramula S, and Lippmann S
- Subjects
- Abdominal Abscess etiology, Adalimumab therapeutic use, Female, Gram-Positive Bacterial Infections etiology, Humans, Micrococcaceae, Middle Aged, Tumor Necrosis Factor-alpha antagonists & inhibitors, Abdominal Abscess microbiology, Adalimumab adverse effects, Arthritis, Rheumatoid drug therapy, Gram-Positive Bacterial Infections microbiology, Immunocompromised Host
- Abstract
A common inhabitant of skin, the Kocuria kristinae of the Micrococcaceae family, has gained attention in recent years because it can induce pathology in humans. Reported is a Kocuria kristinae-caused abdominal abscess in a patient treated for rheumatoid arthritis with adalimumab. The tumor necrosis factor (TNF) inhibitor drugs are known to cause various bacterial, viral, and fungal infections. This is the first known case where an opportunistic infection with Kocuria has presented with an abdominal abscess in an immunocompromised individual who is on long term TNF inhibitors.
- Published
- 2017
- Full Text
- View/download PDF
11. Dying, death, and grief. Helping patients and their families through the process.
- Author
-
Krigger KW, McNeely JD, and Lippmann SB
- Subjects
- Counseling, Humans, Physician's Role, Physicians psychology, Professional-Family Relations, Attitude to Death, Grief, Physician-Patient Relations
- Abstract
When a patient has terminal illness and death is imminent, grief is a normal reaction. Primary care physicians can help patients and their families by talking with them about the five stages of grief (denial, anger, bargaining, depression, and acceptance), providing grief counseling and appropriate pharmacotherapy, and being supportive. Grief often manifests with features similar to those of depression, and it is critical for the clinician to distinguish between the two. One distinguishing feature is that self-esteem in the grieving person is usually uncompromised, whereas a depressed person often has decreased self-esteem. Physicians should also watch for signs of mood disorders or abnormal grief. When grief is present more than 2 months after a loss, a diagnosis of major depression should be considered. Dysfunctional grief accompanied by severe depression and suicidal intent generally calls for psychiatric referral, hospitalization, or both.
- Published
- 1997
- Full Text
- View/download PDF
12. Treatment of insomnia. Getting to the root of sleeping problems.
- Author
-
Pary R, Tobias CR, Webb WK, and Lippmann SB
- Subjects
- Anti-Anxiety Agents therapeutic use, Behavior Therapy, Benzodiazepines, Humans, Sleep Initiation and Maintenance Disorders diagnosis, Sleep Initiation and Maintenance Disorders etiology, Sleep Initiation and Maintenance Disorders therapy
- Abstract
Insomnia may be periodic and transient, as caused by situational stress, or persistent, as caused by a chronic sleep disorder. Physicians can gain much information concerning the type, probable cause, onset, and duration of insomnia through history taking. A sleep diary may reveal helpful information, and input from the patient's sleeping partner can also be valuable. Complicating disorders, such as heart failure, prostatism, or depression, should be sought and specific treatment prescribed. Chemical dependency, too, requires appropriate treatment. These measures, institution of good sleep-hygiene practices, and behavior modification may resolve sleeplessness. The primary indication for use of hypnotic agents is transient sleep disruption caused by acute stress. When an agent is chosen, onset of action, metabolism, and side effects should be considered, especially in elderly patients. Addictive agents should not be given to patients with substance abuse problems. If insomnia persists, evaluation at a sleep-disorder center is recommended to facilitate design of an appropriate therapeutic regimen.
- Published
- 1996
- Full Text
- View/download PDF
13. Delirium. Quick recognition, careful evaluation, and appropriate treatment.
- Author
-
Casey DA, DeFazio JV Jr, Vansickle K, and Lippmann SB
- Subjects
- Diagnosis, Differential, Humans, Delirium diagnosis, Delirium etiology, Delirium psychology, Delirium therapy
- Abstract
Delirium is a common medical condition, especially in elderly hospitalized patients. The syndrome is characterized by a short course of confusion and changes in perception and behavior. Early detection can be enhanced by routine assessment of cognitive functioning in hospitalized patients, especially those at risk for delirium. Prompt recognition and aggressive treatment of the underlying cause are essential for a positive outcome. Supportive measures are designed to calm and protect the patient and provide symptomatic relief until the precipitating condition is corrected.
- Published
- 1996
- Full Text
- View/download PDF
14. Alcoholism. Taking a preventive, public health approach.
- Author
-
Blondell RD, Frierson RL, and Lippmann SB
- Subjects
- Alcoholism complications, Alcoholism rehabilitation, Chronic Disease, Humans, Mental Disorders complications, Primary Prevention, Alcoholism prevention & control
- Abstract
Alcoholism is a common, chronic, often progressive disorder that has negative effects on a patient's health and severe consequences for society as well. A positive, public health approach that integrates medical, psychological, and social therapies can lead to improved outcomes for patients who abuse alcohol. Physicians can play an important role by educating patients to prevent alcohol abuse from starting, being alert to the risk factors, recognizing the signs of alcoholism (especially during its early stages), and initiating interventions designed to halt progression of this disease. Doctors should maintain a therapeutic stance with patients who have continued to abuse alcohol, even after frequent relapses. Consultation with alcoholism experts may be helpful when treatment is difficult or there is the possibility of a dual diagnosis.
- Published
- 1996
- Full Text
- View/download PDF
15. Domestic violence. Do you know when and how to intervene?
- Author
-
Steiner RP, Vansickle K, and Lippmann SB
- Subjects
- Aged, Child, Child Abuse diagnosis, Community Health Services, Documentation, Elder Abuse diagnosis, Female, Humans, Male, Spouse Abuse diagnosis, United States, Domestic Violence, Physician's Role
- Abstract
Physicians must be alert to the possibility of abuse within the family and home. They should be well prepared to help victims begin the transition to a safer environment. An awareness of the prevalence of abuse and a high index of suspicion are the most effective clinical tools for assisting victims of domestic violence. In addition, physicians need to be familiar with reporting laws in their states. Comprehensive management includes not only treatment but also investigation of injuries, reporting of suspected abuse, referral to appropriate community agencies for violence management or counseling, and addressing underlying chemical dependency or mental disorders. Close follow-up is critical to both detection and prevention. Physicians are obliged not only to treat individuals but also to support social policies that reduce family violence.
- Published
- 1996
- Full Text
- View/download PDF
16. Clues to depression in primary care practice.
- Author
-
el-Mallakh RS, Wright JC, Breen KJ, and Lippmann SB
- Subjects
- Antidepressive Agents therapeutic use, Depressive Disorder complications, Humans, Psychotherapy, Risk Factors, Suicide psychology, Suicide Prevention, Depression diagnosis, Depression therapy, Depressive Disorder diagnosis, Depressive Disorder therapy, Family Practice
- Abstract
Depression is a common but highly treatable mood disorder. Unfortunately, two thirds of depressed patients may never receive appropriate intervention. Because of individual and societal barriers to the diagnosis, depressive symptoms often go unrecognized. However, primary care physicians are in a unique position to surmount these obstacles by being alert to manifestations of the disorder. Treatment with antidepressant drugs, psychotherapy, electroconvulsive therapy, or a combination of these is very efficacious. The choice of method is based on such factors as history of previous response, severity of disease, concomitant medical illness, and patient preference.
- Published
- 1996
- Full Text
- View/download PDF
17. Chronic schizophrenia. Options for pharmacologic management.
- Author
-
Pary R, Tobias CR, and Lippmann S
- Subjects
- Antipsychotic Agents administration & dosage, Chronic Disease, Clozapine therapeutic use, Drug Therapy, Combination, Humans, Lithium administration & dosage, Psychotropic Drugs administration & dosage, Risperidone therapeutic use, Antipsychotic Agents therapeutic use, Schizophrenia drug therapy
- Published
- 1995
18. Chronic schizophrenia.
- Author
-
Pary R, Tobias CR, and Lippmann S
- Abstract
Preview Perhaps one fourth of patients with schizophrenia respond only partially to standard neuroleptic therapy. Until recently, the only pharmacologic option for such patients was adjunctive treatment with other psychotropic drugs. Now two newer drugs-clozapine and risperidone-offer hope to patients with treatment-resistant schizophrenia. This article provides an up-to-date look at effective treatment of this troubling disorder.
- Published
- 1995
- Full Text
- View/download PDF
19. Obsessive-compulsive disorder. How to free patients from intrusive thoughts and rituals.
- Author
-
Pary R, Lippmann S, and Tobias CR
- Subjects
- Antidepressive Agents administration & dosage, Antidepressive Agents therapeutic use, Behavior Therapy, Humans, Obsessive-Compulsive Disorder psychology, Obsessive-Compulsive Disorder therapy
- Abstract
The antidepressants clomipramine hydrochloride (Anafranil), fluoxetine hydrochloride (Prozac), and sertraline hydrochloride (Zoloft) are the main choices for pharmacologic treatment of obsessive-compulsive disorder. Often, drug doses for obsessive-compulsive disorder are higher than for depression, and improvement occurs more slowly and is often only partial. Behavior therapy involving exposure to feared objects or situations and prevention of ritualistic behavior complements pharmacologic treatment. Referral to a behavioral therapist may be necessary to achieve recovery.
- Published
- 1994
20. Obsessive-compulsive disorder.
- Author
-
Pary R, Lippmann S, and Tobias CR
- Abstract
Preview Enormous amounts of time and energy may be consumed by persons with obsessive-compulsive disorder, who think distressing thoughts and then feel compelled to act on them repeatedly. How common is obsessive-compulsive disorder? What are its typical clinical presentations? The authors of this article answer these questions and discuss pharmacologic and behavior therapy.
- Published
- 1994
- Full Text
- View/download PDF
21. Phobias. How to help patients overcome irrational fears.
- Author
-
Blumenreich PE and Lippmann SB
- Subjects
- Desensitization, Psychologic, Diagnosis, Differential, Humans, Phobic Disorders complications, Phobic Disorders diagnosis, Phobic Disorders therapy, Psychotherapy
- Abstract
When phobias compromise a person's normal lifestyle or cause ongoing anxiety, they must be dealt with. Irrational, persistent fears may lead to isolation, depression, even substance abuse. What are the features of agoraphobia? Social phobia? Simple phobia? How common are these anxiety disorders? The authors answer these questions and discuss differential diagnosis and treatment options.
- Published
- 1994
22. Wilson's disease. Psychiatric manifestations may be the clinical presentation.
- Author
-
Jackson GH, Meyer A, and Lippmann S
- Subjects
- Clonazepam therapeutic use, Copper blood, Copper urine, Cornea pathology, Diagnosis, Differential, Hepatolenticular Degeneration blood, Hepatolenticular Degeneration diagnosis, Hepatolenticular Degeneration drug therapy, Hepatolenticular Degeneration urine, Humans, Liver Function Tests, Male, Medical History Taking, Middle Aged, Penicillamine therapeutic use, Physical Examination, Hepatolenticular Degeneration complications, Mental Disorders etiology
- Abstract
It is important to consider Wilson's disease in patients with psychiatric signs and symptoms who also have abnormal liver function test results or neurologic findings, or both. Thorough evaluation of emotionally disturbed persons, including complete history taking, careful physical examination, and appropriate laboratory profile, generally rules out or arouses suspicion of Wilson's disease during routine screening. Laboratory abnormalities necessitate repeated studies and additional family and personal history taking with emphasis on possible Wilson's disease. Further workup may then be indicated. Prompt recognition and vigorous, consistent treatment can minimize symptoms and tissue damage. Identifying a case of Wilson's disease and seeing clinical aspects improve with appropriate therapy is gratifying.
- Published
- 1994
23. Wilson's disease.
- Author
-
Jackson GH, Meyer A, and Lippmann S
- Abstract
Preview An anxious, paranoid, disoriented patient usually requires psychiatric referral. Occasionally, such features are the first noticeable indication of an inherited copper-storage disorder. The authors describe accompanying hepatic and neurologic findings that characterize Wilson's disease and describe their recent experience in diagnosing and treating a patient with this uncommon disease.
- Published
- 1994
- Full Text
- View/download PDF
24. AIDS and the family: implications for counselling.
- Author
-
Lippmann SB, James WA, and Frierson RL
- Subjects
- Adaptation, Psychological, Caregivers psychology, Gender Identity, Grief, Humans, Suicide psychology, Terminal Care psychology, Acquired Immunodeficiency Syndrome psychology, Family psychology, Family Therapy, Sick Role
- Abstract
The presence of HIV spectrum illness stimulates a powerful emotional reaction from a patient's family and friends. Grief and shock over the infection, and its implications are frequent observations. Sadness, anxiety, helplessness and anger are also common. Health care staff should address these responses in order to strengthen coping skills and maximize interpersonal comfort. Stigmatization and isolation are major stressors. Bereavement is complicated by fear, shame, dependency and hopelessness. Therefore, a task in counselling is to maintain the integrity and supportiveness of the patient's social unit by encouraging open communications between those involved and by educating about AIDS. Information should be provided on HIV transmission, self-protection, and illness progression as well as the safety of causal contacts and the practices of 'safer sex'. The significant others should retain outside interests and be encouraged to seek help for patients from supportive social agencies. Instillation of hope lends benefit to patient, family and friends. Kind, non-judgmental counselling and good quality medical care should be made available, especially since HIV-related disorders are increasingly becoming a chronic disease. Advocacy for the significant others translates into better adjustment and it enhances the patient's medical prognosis.
- Published
- 1993
- Full Text
- View/download PDF
25. Violent patients. Are you prepared to deal with them?
- Author
-
Blumenreich P, Lippmann S, and Bacani-Oropilla T
- Subjects
- Anti-Anxiety Agents administration & dosage, Anti-Anxiety Agents pharmacokinetics, Anti-Anxiety Agents therapeutic use, Antipsychotic Agents administration & dosage, Antipsychotic Agents therapeutic use, Clinical Protocols standards, Education, Medical, Continuing, Humans, Liability, Legal, Patient Isolation, Predictive Value of Tests, Restraint, Physical adverse effects, Restraint, Physical methods, Risk Factors, Aggression psychology, Physician's Role, Violence
- Abstract
The medical community is becoming increasingly concerned about violent patients in healthcare settings. Healthcare professionals should be trained to deal with aggressive patients, and they should have access to a room free of dangerous objects for evaluation and examination. Having security personnel stand by may be appropriate in some cases. Verbal intervention is the key to dealing with violent patients. The safest and most effective pharmacologic intervention is use of benzodiazepines, either alone or in conjunction with antipsychotic agents when indicated. Seclusion or restraint may be needed for some violent patients; in such situations, close patient monitoring and explicit documentation are essential. Physicians can be held liable for injuries patients sustain while being restrained, so staff members should receive instruction in safe physical intervention techniques.
- Published
- 1991
- Full Text
- View/download PDF
26. Anorexia nervosa in males.
- Author
-
Barry A and Lippmann SB
- Subjects
- Adaptation, Psychological, Adolescent, Adult, Anorexia Nervosa diagnosis, Anorexia Nervosa therapy, Body Image, Child, Dependency, Psychological, Diagnosis, Differential, Gender Identity, Homosexuality psychology, Humans, Internal-External Control, Male, Prognosis, Social Values, Anorexia Nervosa psychology
- Abstract
Although anorexia nervosa is usually considered a disorder of young women and girls, 5% to 10% of cases occur in men and boys. Onset can range from prepubertal years to adulthood. The unique conflicts that may lead to anorexia nervosa in males must be considered when treating these patients.
- Published
- 1990
- Full Text
- View/download PDF
27. How do eating disorders affect thyroid function?
- Author
-
Marshall Z and Lippmann S
- Subjects
- Adult, Female, Humans, Male, Thyroid Function Tests, Feeding and Eating Disorders blood, Thyroid Hormones blood
- Abstract
Abnormal thyroid function in patients with eating disorders can result from malnutrition. A low serum triiodothyronine (T3) level is commonly noted in starvation states and is caused by reduced peripheral conversion of thyroxine (T4) to T3. Diminished T4 concentrations are also observed. Adequate nutrition normalizes this type of aberrant laboratory profile. Thyroid function tests that give results below the normal range are best repeated initially for verification of results and again after adequate nutrition is reestablished. If no primary endocrinopathy is present, spontaneous correction of these laboratory values can be expected with conventional dietary habits.
- Published
- 1987
- Full Text
- View/download PDF
28. Hemoglobin C in association with hereditary persistence of fetal hemoglobin.
- Author
-
Martin AW, Lippmann SB, Keeling MM, Lynch JA, and Martinez M
- Subjects
- Adult, Hemoglobin C analysis, Hemoglobin C Disease blood, Hemoglobin C Disease genetics, Hemoglobinopathies blood, Hemoglobinopathies genetics, Humans, Male, Fetal Hemoglobin analysis, Hemoglobin C Disease diagnosis, Hemoglobinopathies diagnosis
- Abstract
Hemoglobin C and hereditary persistence of fetal hemoglobin (HPFH) are an uncommon combination of hemoglobinopathies. Several tests are needed to verify this condition, among them hemoglobin electrophoresis and Kleihauer-Betke staining of a peripheral blood smear. Family studies are useful in delineating the genetics of the hemoglobinopathy but could not be performed in our case. In more confusing cases or with an unusual subtype, more extensive testing may be required. HPFH, by itself, is without clinical manifestations. It may be confused with other conditions; therefore, its presence in patients with hematologic symptoms requires more precise definition of the hemoglobin abnormality.
- Published
- 1987
- Full Text
- View/download PDF
29. Delirium in the elderly. A commonly misunderstood disorder.
- Author
-
Tobias CR, Lippmann S, Tully E, Pary R, and Turns DM
- Subjects
- Aged, Dementia diagnosis, Diagnosis, Differential, Humans, Delirium diagnosis, Delirium etiology, Delirium therapy
- Published
- 1989
- Full Text
- View/download PDF
30. Antidepressants and the cardiac patient. Selecting an appropriate medication.
- Author
-
Pary R, Tobias CR, and Lippmann S
- Subjects
- Antidepressive Agents adverse effects, Antidepressive Agents, Tricyclic adverse effects, Antidepressive Agents, Tricyclic therapeutic use, Blood Pressure drug effects, Depressive Disorder complications, Depressive Disorder drug therapy, Drug Interactions, Electrocardiography, Heart Conduction System physiopathology, Heart Diseases complications, Heart Rate drug effects, Humans, Monoamine Oxidase Inhibitors adverse effects, Monoamine Oxidase Inhibitors therapeutic use, Antidepressive Agents therapeutic use, Heart Diseases physiopathology
- Published
- 1989
- Full Text
- View/download PDF
31. Drug therapy for depression in the elderly.
- Author
-
Lippmann S
- Subjects
- Aged, Antidepressive Agents administration & dosage, Antidepressive Agents adverse effects, Antidepressive Agents metabolism, Antidepressive Agents, Tricyclic therapeutic use, Arrhythmias, Cardiac chemically induced, Depression diagnosis, Heart Conduction System drug effects, Humans, Monoamine Oxidase Inhibitors therapeutic use, Antidepressive Agents therapeutic use, Depression drug therapy
- Abstract
Depression is common in the geriatric population, but recovery rates are gratifying. Safe treatment requires attention to the effects of aging on pharmacokinetics and close monitoring. Antidepressants are the drugs most commonly used; to the standard tricyclic drugs have now been added a tetracyclic and a triazolopyridine. Monoamine oxidase inhibitors and lithium are second-choice options; a benzodiazepine is not generally required. Dosages should be lower than conventionally prescribed. Side effects of antidepressant drugs are common, the most important being slowing of cardiac conduction times and the most common being anticholinergic manifestations, such as dry mouth and tachycardia. Some of the more recently introduced antidepressants may have more advantageous side-effect profiles than the older agents.
- Published
- 1983
- Full Text
- View/download PDF
32. Detection of unknown early pregnancy. A matter of safety.
- Author
-
Lippmann S, Bordador B, and Shaltout T
- Subjects
- Accidents, Traffic, Adult, Female, Humans, Multiple Trauma, Pregnancy, Pregnancy Complications, Time Factors, Chorionic Gonadotropin blood, Pregnancy Tests
- Abstract
Almost 2% of females admitted as accident victims to a general hospital-teaching facility were pregnant without their physicians knowing it. Emergency treatment of such patients may overshadow other aspects of holistic care and have adverse consequences when a pregnancy is unrecognized. These cases illustrate the importance of always performing a complete physical examination and obtaining a good history that includes menstrual data. When appropriate, we recommend routine use of the serum human chorionic gonadotropin test for pregnancy. It is a simple and reliable means of detecting pregnancy by ten days after nidation, and its use protects the patient, physician, and unborn child. Safer health service is the result.
- Published
- 1988
- Full Text
- View/download PDF
33. Lithium's effects on the kidney.
- Author
-
Lippmann S
- Subjects
- Diuretics therapeutic use, Humans, Kidney drug effects, Kidney Concentrating Ability drug effects, Lithium administration & dosage, Lithium blood, Polyuria chemically induced, Kidney Diseases chemically induced, Lithium adverse effects
- Abstract
Although lithium was known to cause changes in renal physiology, it was considered safe until reports in late 1977 suggested that it may induce chronic irreversible nephropathy. Later reports documented similar lesions in non-lithium-treated patients with affective disturbances. Thus, the data are inconclusive. Concern for the kidney during lithium therapy is now greater than it was originally, but confidence in lithium's safety is higher than it has been for the past four years. Physician appreciation of the foregoing factors, careful patient selection, and informed consent are important in lithium therapy. An understanding of lithium use in patients in a low-sodium state or on diuretic therapy and avoidance and treatment of lithium intoxication are advocated. Good prelithium workups and closer monitoring of patients on long-term lithium therapy are recommended.
- Published
- 1982
- Full Text
- View/download PDF
34. Use of antipsychotic drugs in depression. Problems and opportunities.
- Author
-
Wright JH and Lippmann SB
- Subjects
- Antidepressive Agents, Tricyclic adverse effects, Antidepressive Agents, Tricyclic therapeutic use, Antipsychotic Agents adverse effects, Depressive Disorder diagnosis, Dyskinesia, Drug-Induced etiology, Humans, Antipsychotic Agents therapeutic use, Depressive Disorder drug therapy
- Abstract
Antipsychotic drugs have an important place in pharmacologic treatment of depression. Major depression with psychotic features responds poorly to treatment if an antipsychotic is not used in addition to an antidepressant; however, an antipsychotic confers no additional benefit in nonpsychotic depression. Antipsychotic drugs do have significant short- and long-term side effects, including pseudoparkinsonism, dystonia, akathisia, and tardive dyskinesia. The possibility of a good therapeutic response with minimal side effects can be increased if psychotic depression is diagnosed accurately and the antipsychotic is prescribed according to established clinical guidelines.
- Published
- 1987
- Full Text
- View/download PDF
35. Dementia in the elderly.
- Author
-
Tobias CR, Lippmann S, and Pary R
- Subjects
- Aged, Aging psychology, Cognition, Dementia etiology, Dementia therapy, Diagnosis, Differential, Humans, Memory Disorders etiology, Dementia diagnosis
- Abstract
When are confusion and forgetfulness transient signs of normal aging, when are they signs of depression or a medical illness, and when are they signs of dementia? The authors describe clinical features and diagnostic studies that help establish the presence of dementia and discuss ways of coping with both remediable and less treatable types.
- Published
- 1989
- Full Text
- View/download PDF
36. Psychiatric disorders in the elderly. Psychopharmacologic management.
- Author
-
Tobias CR, Turns DM, Lippmann S, Pary R, and Embry CK
- Subjects
- Alcoholism drug therapy, Humans, Aged psychology, Anxiety Disorders drug therapy, Delirium drug therapy, Dementia drug therapy, Depression drug therapy, Psychotic Disorders drug therapy
- Abstract
Psychiatric management of elderly patients is a challenging task because of the many age-related physiologic changes and medical problems in this population. Thorough patient evaluation is essential to rule out somatic disorders and determine underlying causes. Somatic complaints must be taken seriously, even if a patient is receiving treatment for a psychiatric disorder. Psychotropic therapy is used mainly for controlling depression, agitation, and psychotic symptoms. If psychiatric symptoms persist or become worse, psychotropics should be discontinued to prevent possible drug toxicity (eg, anticholinergic delirium) and psychiatric consultation should be requested.
- Published
- 1988
- Full Text
- View/download PDF
37. Should the mentally ill adopt children? How physicians can influence the decision.
- Author
-
Bacani-Oropilla T, Lippmann SB, and Turns DM
- Subjects
- Adult, Bipolar Disorder psychology, Child, Child Custody, Child, Preschool, Female, Humans, Male, Parents, Physician's Role, Stress Disorders, Post-Traumatic psychology, Adoption, Mental Disorders psychology
- Abstract
No established criteria exist for determining whether a person with a mental illness should or should not be allowed to adopt children. The basis for opinion in such cases can be derived from previous custody cases described in the literature. The interest of the potential parent, as well as the child, must be a primary consideration. Physicians are often called on to make recommendations regarding the parental fitness of a mentally ill person. An intensive assessment of the potential adoptive parent, including a thorough history and investigation of the person's resources and support systems, is necessary before a recommendation can be made.
- Published
- 1988
- Full Text
- View/download PDF
38. Alcoholism in the elderly. How to spot and treat a problem the patient wants to hide.
- Author
-
Tobias CR, Lippmann S, Pary R, Oropilla T, and Embry CK
- Subjects
- Aged, Alcohol Withdrawal Delirium drug therapy, Alcoholics Anonymous, Alcoholism complications, Alcoholism rehabilitation, Alcoholism therapy, Disulfiram therapeutic use, Drug Interactions, Ethanol blood, Humans, Personality, Self Disclosure, Vitamins therapeutic use, Alcoholism diagnosis
- Abstract
Alcoholism is a disease that warrants a complete medical workup and vigorous intervention in all age-groups, including the elderly. Increased awareness of the problem, with early diagnosis and treatment, can reduce mortality and morbidity. Alcoholics are at risk for relapse, so physicians should be patient and positive in their approach. Especially in the elderly, obtaining a list of all prescribed and over-the-counter medications used is an important starting point. Nonessential drugs should be discontinued and use of any others closely monitored. If a withdrawal syndrome results from discontinuation of alcohol, thiamine, multivitamins, and sedatives should be prescribed as clinically indicated. Treatment of any underlying psychiatric disorder is important. Psychosocial intervention is essential in dealing with recovering elderly alcoholics to overcome loneliness and to enhance sobriety. A formal rehabilitative effort is mandatory. Long-term rehabilitation focuses on group support and may include use of disulfiram (Antabuse).
- Published
- 1989
- Full Text
- View/download PDF
39. Chronic depression. Issues in long-term management.
- Author
-
Bacani-Oropilla T and Lippmann SB
- Subjects
- Aged, Chronic Disease, Humans, Long-Term Care, Male, Quality of Life, Recurrence, Amitriptyline administration & dosage, Depressive Disorder drug therapy
- Abstract
Patients with protracted depression respond well to long-term maintenance antidepressant therapy. A precise diagnosis is a prerequisite to therapeutic decisions. Diagnosis may be missed and treatment inadequate if symptoms are attributed solely to aging or to life's circumstances. Proper dosage is determined by the patient's age and metabolic capabilities, and patient education increases compliance. Although the patient may deny the need for psychotherapy, continued support and a life review help the patient acquire insights and adjust to changes. The patient can sustain progress by keeping active, pursuing interests, and socializing. The aim of long-term antidepressant pharmacotherapy is to reduce morbidity, restore productive and optimal functioning, and enhance the quality of life. The attainment of previous levels of function is the gauge of success.
- Published
- 1989
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.